Background: Healthcare has a major impact on climate change, and surgery is among the most energy-intensive hospital practices. Although most Americans believe climate change is happening, little is known regarding public awareness of the impact of healthcare on climate change and how this may impact perceptions of plastic surgery. Methods: A cross-sectional survey was administered to adults in the United States using Amazon Mechanical Turk in December 2021 to assess public perceptions of climate change, healthcare, and plastic surgery. Incomplete responses were excluded from analysis. Multivariable logistic regression models were used to determine predictors of responses. Results: There were 890 complete responses. Most participants strongly agreed or agreed that climate change is happening (89%). Fewer believed that healthcare has an impact on climate change (62%), with greater odds among respondents with an associate’s degree or higher (odds ratio 2.8, P < 0.001). After they were given information about the impact of healthcare on climate change, most respondents were more worried about the effects of cosmetic plastic surgery (64%). Many respondents would be willing to engage in personal climate change mitigation measures if undergoing surgery and pay higher professional fees to support sustainable hospital practices. Conclusions: Most Americans believe climate change is happening, but fewer believe healthcare has an impact on climate change. Knowledge regarding the impact of healthcare and surgery on climate change may make patients more worried about the effects of plastic surgery on climate change, but patients may be willing to personally mitigate climate impacts of surgery.
Background:The US Food and Drug Administration (FDA) issued a boxed warning on breast implants in October 2021, requiring communication of certain risks to patients. This study assessed how this boxed warning may impact public perceptions of breast implants. Methods: A cross-sectional survey was administered to adult women in the United States in December 2021 using Amazon Mechanical Turk to assess perceptions of breast implant risks communicated in the FDA-issued guidance. Sociodemographic predictors of responses were identified using multivariable models. Results: There were 494 complete responses. Respondents had a mean age of 36.9 years, and 80% had an associate's degree or higher. At baseline, most would consider receiving implants for reconstructive or cosmetic purposes (65%). Some were unsure or indicated that it is not possible to undergo mammograms after receiving implants (42%). After provided information in the FDA guidance, the majority strongly agreed or agreed that they were less likely to receive implants knowing the risk of anaplastic large cell lymphoma (75%), because implants contain chemicals/heavy metals (74%), and because implants are not lifetime devices (68%), with greater odds among Hispanic respondents (OR, 2.35; P < 0.01) and lower odds among higher-income respondents (OR, 0.64; P = 0.03). Conclusions: There are misconceptions with regard to breast implant-associated risks. Despite most laywomen indicating that they would consider receiving implants at baseline, the risks communicated in the 2021 FDA boxed warning may make patients less likely to receive implants, with variability among different sociodemographic populations.
PRS Global Open • 2022 of GWAS) -to define the genomic regions demonstrating overlap in genetic architecture between the two diseases. RESULTS:Within the cohort of 401,656 white, British individuals, there were 12,312 CTS cases and 14,453 migraine cases. With migraine as the exposure, the odds ratio (OR) for association with CTS was 1.14 (95% CI: 1.04 -1.25; p=0.006). Sex-stratified analysis revealed a significant association in females (OR=1.15; 95% CI: 1.04 -1.28, p=0.006) but not in males (OR=1.07; 95% CI: 0.82 -1.40, p=0.61). Matching on BMI in addition to age and sex had the effect of marginally increasing the odds ratio in the female-specific (OR=1.17; 95% CI: 1.06 -1.29, p=0.002) and overall cohort (OR=1.15; 95% CI: 1.04 -1.26, p=0.004). We found a statistically significant positive genetic correlation between migraine and CTS (r=0.12, p=0.004), and the CPASSOC/MTAG analyses highlighted a region on chromosome 9 where there was strong evidence of genetic overlap. One particular genetic variant, rs1040851, was strongly associated with both diseases (MTAG p-values: CTS, 3.87Ã-10^-5; migraine, 1.32Ã-10^-12), and this variant is known to affect the expression levels of the TRIM32 gene.
This study investigated the differences in amplitude discrimination capacity between two stimuli delivered to adjacent fingertips on the same hand (contralateral delivery) and stimuli delivered to two fingers on opposite hands (bilateral delivery). The measures were obtained in order to study the impact of lateral inhibition via interhemispheric connections on cortical centers on opposite sides of the somatosensory cortex in comparison to lateral inhibition occurring between adjacent cortical centers within the same hemisphere. Using the Cortical Metrics Brain Gauge™ device, amplitude discrimination capacity of 37 healthy subjects was assessed at several different durations, ranging from 40 to 500 msec, of vibrotactile stimulation delivered contralaterally and bilaterally. The results demonstrate a significant difference in amplitude discrimination capacity between the two conditions for stimulus duration of 200ms, with performance being better for the contralateral delivery of the stimuli than the bilateral condition for most tested durations. Task performance was roughly the same for the two conditions at the extremes of short (40ms) and long (500ms) stimulus durations. Amplitude discrimination capacity improved with longer stimulus durations in both bilateral and contralateral conditions. Though slight variation was observed at the level of each individual subject, overall, it is clear that local lateral inhibition plays a role in assessing the two stimuli delivered to the same hand that gives same-handed discrimination an advantage over two-handed discrimination. Additionally, the trends identified may be useful in guiding future experimentation that investigates clinical assessments of deficits in cortical processing that is mediated by callosal connections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.